
The treatment is to protect children under two years of age from respiratory syncytial virus

Hypertension affects more than 1.4 billion people worldwide and many patients remain uncontrolled despite multiple therapies

In 2026, an estimated 22,720 people in the US will be diagnosed with AML

Taken at any time of the day, the oral GLP-1 is the only pill to have no food or water restrictions

The autoimmune disease affects approximately three to five million people globally

Onureg is the oral version of Vidaza, two of the drugs BMS gained as part of its acquisition of Celgene in 2019

Partner companies could gain $2.5bn in milestone payments

Glasdegib first to show benefit in patients with AML or MDS